GlassScriptPrepare for your visit
Alvaro Moreno
Optometrist · Petal, MS · NPI 1548347834
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,896.20
in general payments reported to CMS, 2019-2025 · $668 in 2025
The $668 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Who reported paying
General payments only, top 6 by amount.
- Coopervision INC. $1,012.48
- Alcon Vision LLC $494.07
- Oyster Point Pharma, INC. $98.08
- Tarsus Pharmaceuticals, INC. $81.38
- Bausch & Lomb Americas INC. $73.84
- Bausch & Lomb, A Division of Bausch Health US, LLC $64.37
Drugs and devices associated with these payments
Myday Contact Lens Clariti Contact Lens Total30 Precision7 Biofinity Contact Lens Xdemvy Xiidra Miebo Tyrvaya Precision 1
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Alvaro Moreno listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/252167/alvaro-moreno